Literature DB >> 7828963

Cell biology of liver endothelial and Kupffer cells.

B Smedsrød1, P J De Bleser, F Braet, P Lovisetti, K Vanderkerken, E Wisse, A Geerts.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7828963      PMCID： PMC1375602          DOI： 10.1136/gut.35.11.1509

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  132 in total

1.  Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation.

Authors:  D L Knook; E C Sleyster
Journal:  Exp Cell Res       Date:  1976-05       Impact factor: 3.905

2.  Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats.

Authors:  L Bouwens; D L Knook; E Wisse
Journal:  J Leukoc Biol       Date:  1986-06       Impact factor: 4.962

3.  Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver.

Authors:  L Bouwens; M Baekeland; R De Zanger; E Wisse
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

4.  Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells.

Authors:  E Wisse
Journal:  J Ultrastruct Res       Date:  1974-03

5.  Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope.

Authors:  E Wisse
Journal:  J Ultrastruct Res       Date:  1974-03

6.  Liver as a tumor cell killing organ: Kupffer cells and natural killers.

Authors:  M Malter; E Friedrich; R Süss
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

7.  Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.

Authors:  H Prytz; J Holst-Christensen; B Korner; H Liehr
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

8.  In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.

Authors:  T Daemen; A Veninga; F H Roerdink; G L Scherphof
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

9.  Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

Authors:  S Moncada; E A Higgs; J R Vane
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

10.  Endotoxin and bacteria in portal blood.

Authors:  A I Jacob; P K Goldberg; N Bloom; G A Degenshein; P J Kozinn
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682
View more
  45 in total

1.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

2.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

3.  Biomaterials for liver tissue engineering.

Authors:  Era Jain; Apeksha Damania; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-27       Impact factor: 6.047

4.  Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells.

Authors:  Shyam Sundhar Bale; Inna Golberg; Rohit Jindal; William J McCarty; Martha Luitje; Manjunath Hegde; Abhinav Bhushan; Osman Berk Usta; Martin L Yarmush
Journal:  Tissue Eng Part C Methods       Date:  2014-11-06       Impact factor: 3.056

Review 5.  New cellular and molecular targets for the treatment of portal hypertension.

Authors:  Jordi Gracia-Sancho; Raquel Maeso-Díaz; Anabel Fernández-Iglesias; María Navarro-Zornoza; Jaime Bosch
Journal:  Hepatol Int       Date:  2015-03-05       Impact factor: 6.047

6.  Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation.

Authors:  M K Bijsterbosch; E T Rump; R L De Vrueh; R Dorland; R van Veghel; K L Tivel; E A Biessen; T J van Berkel; M Manoharan
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

7.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

Review 8.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

Review 9.  Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Authors:  Keisaku Sato; Chad Hall; Shannon Glaser; Heather Francis; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2016-07-22       Impact factor: 4.307

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.